We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring (INFORM)

This study has been terminated.
(Sponsor's decision.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00707512
First Posted: July 1, 2008
Last Update Posted: July 20, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Biogen
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2050
  Estimated Primary Completion Date: August 2050 (Final data collection date for primary outcome measure)